Pirovino M, Ohnhaus E E, von Felten A
Eur J Clin Pharmacol. 1981 Feb;19(3):205-7. doi: 10.1007/BF00561950.
A 60-year-old male patient had two episodes of thrombocytopaenia whilst being treated with digoxin, each of them reversible upon withdrawal of the drug. Bone marrow examination was consistent with peripheral platelet destruction as the main mechanism of the thrombocytopaenia. The inhibition of clot retraction test was positive, with a declining titer, after cessation of digoxin therapy, and this plus the finding of circulating immune complexes after incubation of the patient's serum with digoxin established digoxin as the offending agent. It is concluded that digoxin may be a rare cause of drug-induced immune-thrombocytopaenia.
一名60岁男性患者在接受地高辛治疗期间出现两次血小板减少,每次在停药后均可逆。骨髓检查结果与外周血小板破坏作为血小板减少的主要机制相符。地高辛治疗停止后,血块退缩试验抑制呈阳性且滴度下降,并且患者血清与地高辛孵育后发现循环免疫复合物,这些均确定地高辛为致病因素。结论是,地高辛可能是药物性免疫性血小板减少症的罕见病因。